Skip to main content

Advertisement

Log in

An exploratory examination of the mechanisms through which pre-quit patch use aids smoking cessation

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale and objectives

Patches are traditionally started on the day a quit attempt begins. Recently, a number of studies have established that the patch’s effectiveness is improved by starting the treatment before quitting [pre-quit patch (PQP) use]. In an exploratory study, we investigate a proposed mechanism through which PQP use might promote abstinence: that PQP reduces satisfaction with smoking (either directly or via craving), which in turn leads to reduction and that smoking reduction promotes abstinence.

Methods

Fifty-seven interested quitters used handheld computers to monitor their smoking satisfaction, withdrawal and smoking in real time for 17 days, leading up to a quit attempt. All participants received 21 mg/24 h patches for 2 weeks before and for up to 10 weeks after quitting. Carbon dioxide (CO)-verified 28-day abstinence was assessed.

Results

During PQP treatment, participants reported significant reductions in both the satisfaction gained from smoking (p < 0.001) and their daily cigarette consumption (p < 0.001). Craving did not decrease; however, there was an interaction between time and nicotine dependence; craving decreased only among low dependent participants. Multilevel structural equation modelling revealed a direct effect of satisfaction on smoking rate. Craving did not mediate this relationship. Smoking reduction during the PQP treatment phase was not significantly associated with abstinence.

Conclusions

The real-time data collection protocol utilised allowed for a fine-grained examination of smoking during PQP treatment. The results suggest that the reduction in daily cigarette smoking typically observed during PQP treatment is due to reductions in satisfaction with smoking. Unlike previous studies, however, smoking reduction was not significantly related to later abstinence, even though the odds ratio was comparably. Potential clinical implications of these findings are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Bates D, Maechler M, Bolker B (2013) lme4: Linear mixed-effects models using S4 classes. R package version 0.999999–2

  • Bauer DJ, Preacher KJ, Gil KM (2006) Conceptualizing and testing random indirect effects and moderated mediation in multilevel models: new procedures and recommendations. Psychol Methods 11:142–163. doi:10.1037/1082-989x.11.2.142

    Article  PubMed  Google Scholar 

  • Bolger N, Laurenceau J-P (2013) Intensive longitudinal methods. An introduction to diary and experience sampling research. Guilford, New York

    Google Scholar 

  • Cahill K, Stevens S, Perera R, Lancaster T (2013) Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev 5: CD009329. doi: 10.1002/14651858

  • Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG (2007) Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav 32:912–923. doi:10.1016/J.Addbeh.2006.06.028

    Article  PubMed  Google Scholar 

  • CDC (2011) Quitting smoking among adults—United States, 2001–2010. Morb Mortal Wkly Rep 60:1513–1519

    Google Scholar 

  • Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR (1995) High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. JAMA-J Am Med Assoc 274:1353–1358. doi:10.1001/jama.274.17.1353

    Article  CAS  Google Scholar 

  • Doll R, Peto R, Boreham J, Sutherland I (2004) Mortality in relation to smoking: 50 years’ observations on male British doctors. Br Med J 328:1519–1528. doi:10.1136/bmj.38142.554479.AE

    Article  Google Scholar 

  • Fagerström KO (2005) Can reduced smoking be a way for smokers not interested in quitting to actually quit? Respiration 72:216–220

    Article  PubMed  Google Scholar 

  • Ferguson SG, Shiffman S (2010) Effect of high-dose nicotine patch on the characteristics of lapse episodes. Health Psychol 29:358–366. doi:10.1037/a0019367

    Article  PubMed  Google Scholar 

  • Ferguson SG, Shiffman S, Gwaltney CJ (2006) Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. J Consult Clin Psychol 74:1153–1161. doi:10.1037/0022-006x.74.6.1153

    Article  PubMed  Google Scholar 

  • Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Wewers ME (2008) Treating tobacco use and dependence: 2008 update. U.S. Department of Health and Human Services. Public Health Service, Rockville

    Google Scholar 

  • Foulds J, Stapleton J, Feyerabend C, Vesey C, Jarvis M, Russell MH (1992) Effect of transdermal nicotine patches on cigarette smoking: a double blind crossover study. Psychopharmacology (Berlin) 106:421–427. doi:10.1007/bf02245429

    Article  CAS  Google Scholar 

  • Frandsen M, Walters J, Ferguson SG (2014) Exploring the viability of using online social media advertisings as a recruitment method for smoking cessation clinical trials. Nicotine Tob Res 16:247–251. doi:10.1093/ntr/ntt157

  • Hammersley R (1994) A digest of memory phenomena for addiction research. Addiction 89:283–293. doi:10.1111/j.1360-0443.1994.tb00890.x

    Article  CAS  PubMed  Google Scholar 

  • HBART (2012) Health behaviour assessment in real time. University of Tasmania, Hobart

    Google Scholar 

  • Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991) The Fagerström test for nicotine dependence—a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86:1119–1127

    Article  CAS  PubMed  Google Scholar 

  • Hughes JR, Carpenter MJ (2006) Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res 8:739–749. doi:10.1080/14622200600789726

    Article  PubMed  Google Scholar 

  • Hughes JR, Lesmes GR, Hatsukami DK, Richmond RL, Lichtenstein E, Jorenby DE, Broughton JO, Fortmann SP, Leischow SJ, McKenna JP, Rennard SI, Wadland WC, Heatley SA (1999) Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res 1:169–174. doi:10.1080/14622299050011281

    Article  CAS  PubMed  Google Scholar 

  • Hughes JR, Rennard SI, Fingar JR, Talbot SK, Callas PW, Fagerström KO (2011) Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial. Nicotine Tob Res 13:955–964. doi:10.1093/ntr/ntr103

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Jha P, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R (2013) 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368:341–350. doi:10.1056/NEJMsa1211128

    Article  CAS  PubMed  Google Scholar 

  • Johnstone E, Brown K, Saunders C, Roberts K, Drury M, Walton R, Murphy M (2004) Level of nicotine replacement during a quit-smoking attempt. Nicotine Tob Res 6:377–379. doi:10.1080/14622200410001676440

    Article  CAS  PubMed  Google Scholar 

  • Levin ED, Westman EC, Stein RM, Carnahan E, Sanchez M, Herman S, Behm FM, Rose JE (1994) Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. J Clin Psychopharmacol 14:41–49

    Article  CAS  PubMed  Google Scholar 

  • Lewis-Esquerre JM, Colby SM, Tevyaw TO, Eaton CA, Kahler CW, Monti PM (2005) Validation of the timeline follow-back in the assessment of adolescent smoking. Drug Alcohol Depend 79:33–43. doi:10.1016/j.drugalcdep.2004.12.007

    Article  PubMed  Google Scholar 

  • Lindson N, Aveyard P (2011) An updated meta-analysis of nicotine preloading for smoking cessation: investigating mediators of the effect. Psychopharmacology (Berlin) 214:579–592. doi:10.1007/s00213-010-2069-3

    Article  CAS  Google Scholar 

  • Muthén LK, Muthén BO (1998–2012) Mplus user’s guide, 7th edn. Muthén & Muthén, Los Angeles

  • Robinson TE, Berridge KC (2003) Addiction. Annu Rev Psychol 54:25–53. doi:10.1146/annurev.psych.54.101601.145237

    Article  PubMed  Google Scholar 

  • Rose JE, Behm FM (2004) Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine Tob Res 6:523–532. doi:10.1080/14622200410001696501

    Article  PubMed  Google Scholar 

  • Rose JE, Behm FM (2013) Adapting smoking cessation treatment according to initial response to precessation nicotine patch. Am J Psychiatry 170:860–867. doi:10.1176/appi.ajp.2013.12070919

    Article  PubMed  Google Scholar 

  • Rose JE, Behm FM, Westman EC, Kukovich P (2006) Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res 8:89–101. doi:10.1080/14622200500431866

    Article  CAS  PubMed  Google Scholar 

  • Rose JE, Herskovic JE, Behm FM, Westman EC (2009) Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. Nicotine Tob Res 11:1067–1075. doi:10.1093/ntr/ntp103

    Article  PubMed  Google Scholar 

  • Rose JE, Behm FM, Walther DM, Johnson C, Uhl GR (2010a) Personalized smoking cessation: interactions between nicotine dose, dependence and quit success genotype score. Mol Med 16:247–253. doi:10.2119/molmed.2009.00159

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rose JE, Salley A, Behm FM, Bates JE, Westman EC (2010b) Reinforcing effects of nicotine and non-nicotine components of cigarette smoke. Psychopharmacology (Berlin) 210:1–12. doi:10.1007/s00213-010-1810-2

    Article  CAS  Google Scholar 

  • Shiffman S, Ferguson SG (2008) Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction 103:557–563. doi:10.1111/j.1360-0443.2008.02138.x

    Article  PubMed  Google Scholar 

  • Shiffman S, Ferguson SG, Gwaltney CJ (2006a) Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy. Psychopharmacology (Berlin) 184:608–618. doi:10.1007/S00213-005-0175-4

    Article  CAS  Google Scholar 

  • Shiffman S, Ferguson SG, Gwaltney CJ, Balabanis MH, Shadel WG (2006b) Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy. Psychopharmacology (Berlin) 184:637–644. doi:10.1007/s00213-005-0184-3

    Article  CAS  Google Scholar 

  • Shiffman S, Scharf DA, Shadel WG, Gwaltney CJ, Dang QY, Paton SM, Clark DB (2006c) Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol 74:276–285. doi:10.1037/0022-006x.74.2.276

    Article  PubMed  Google Scholar 

  • Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG (2008) Use of smoking-cessation treatments in the United States. Am J Prev Med 34:102–111. doi:10.1016/j.amepre.2007.09.033

    Article  PubMed  Google Scholar 

  • Shiffman S, Ferguson SG, Strahs KR (2009) Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial. Am J Prev Med 36:96–104. doi:10.1016/j.amepre.2008.09.039

    Article  PubMed  Google Scholar 

  • Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T (2012) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev.doi: 10.1002/14651858

  • Stewart J, de Wit H, Eikelboom R (1984) Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 91:251–268. doi:10.1037/0033-295x.91.2.251

    Article  CAS  PubMed  Google Scholar 

  • WHO (2012) WHO global report: mortality attributable to tobacco, Geneva: World Health Organisation

  • Wise RA (1996) Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319–340. doi:10.1146/annurev.neuro.19.1.319

    Article  CAS  PubMed  Google Scholar 

  • Zwar N, Richmond R, Borland R, Stillman S, Cunningham M, Litt J (2005) Smoking cessation guidelines for Australian general practice. Aust Fam Physician 34:461–466

    PubMed  Google Scholar 

  • Zwar N, Richmond RL, Borland R, Peters M, Litt J, Bell J, Caldwell B, Ferretter I (2011) Supporting smoking cessation: a guide for health professionals. The Royal Australian College of General Practitioners

Download references

Acknowledgments

This work was supported by an internal grant from the University of Tasmania awarded to SGF. Dr. Ferguson is supported through a fellowship from Cancer Council Tasmania (Australia). The authors would like to thank Isabelle Morris, Jodie Bower and Dr. Mai Frandsen for their assistance with conducting the study and Dr. Julia Walters for feedback on the study design.

Conflict of interest

Through his work at Pinney Associates, SGF provides consulting services to GlaxoSmithKline Consumer Healthcare (GSKCH), makers of nicotine replacement products for smoking cessation. However, GSKCH had no role in the current study, did not support it financially, nor review it prior to submission. NS has nothing to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Natalie Schüz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schüz, N., Ferguson, S.G. An exploratory examination of the mechanisms through which pre-quit patch use aids smoking cessation. Psychopharmacology 231, 2603–2609 (2014). https://doi.org/10.1007/s00213-013-3430-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-013-3430-0

Keywords

Navigation